Most Read Articles

TitleAuthorDate

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors

Erica Chow, Stephen Clement, Rajesh Garg

4 October 2023

The case for a ketogenic diet in the management of kidney disease

Shaminie J Athinarayanan, Caroline G P Roberts, Chandan Vangala, Greeshma K Shetty, Amy L McKenzie, Thomas Weimbs, Jeff S Volek

27 April 2024

Management of type 2 diabetes in chronic kidney disease

Jefferson L Triozzi, L Parker Gregg, Salim S Virani, Sankar D Navaneethan

24 January 2024

Years of potential life lost in pre-diabetes and diabetes mellitus: data from a 40-year follow-up of the Israel study on Glucose intolerance, Obesity and Hypertension

Micha Rapoport, Angela Chetrit, Dror Cantrell, Ilya Novikov, Jesse Roth, Rachel Dankner

24 January 2024

Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study

Francesco Franchi, Dmitry M Yaranov, Fabiana Rollini, Andrea Rivas, Jose Rivas Rios, Latonya Been, Yuma Tani, Masaaki Tokuda, Tetsuo Iida, Noriko Hayashi, Dominick J Angiolillo, Arshag D Mooradian

24 January 2024

Glycemic variability and cardiovascular disease in patients with type 2 diabetes

Marcela Martinez, Jimena Santamarina, Adrian Pavesi, Carla Musso, Guillermo E Umpierrez

24 January 2024

Prevalence of peripheral neuropathy in pre-diabetes: a systematic review

Varo Kirthi, Anugraha Perumbalath, Emily Brown, Sarah Nevitt, Ioannis N Petropoulos, Jamie Burgess, Rebecca Roylance, Daniel J Cuthbertson, Timothy L Jackson, Rayaz A Malik, Uazman Alam

24 January 2024

Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes

Jaejin An, Gregory A Nichols, Lei Qian, Mercedes A Munis, Teresa N Harrison, Zhuoxin Li, Rong Wei, Tracey Weiss, Swapnil Rajpathak, Kristi Reynolds

24 January 2024

Differences in type 2 diabetes risk between East, South, and Southeast Asians living in Singapore: the multi-ethnic cohort

Jowy Yi Hoong Seah, Xueling Sim, Chin Meng Khoo, E Shyong Tai, Rob M van Dam

31 October 2023

Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex

Kaori Kitaoka, Yuichiro Yano, Hajime Nagasu, Hiroshi Kanegae, Noriharu Chishima, Hiroki Akiyama, Kouichi Tamura, Naoki Kashihara

30 May 2024

Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population

Ambily Sivadas, S Sahana, Bani Jolly, Rahul C Bhoyar, Abhinav Jain, Disha Sharma, Mohamed Imran, Vigneshwar Senthivel, Mohit Kumar Divakar, Anushree Mishra, Arpita Mukhopadhyay, Greg Gibson, KM Venkat Narayan, Sridhar Sivasubbu, Vinod ScariaSee the full list of authors

12 March 2024

Incidence and determinants of hypophosphatemia in diabetic ketoacidosis: an observational study

Amarens van der Vaart, Femke Waanders, André P van Beek, Titia M Vriesendorp, B H R Wolffenbuttel, Peter R van Dijk

24 January 2024

100 years on: the impact of the discovery of insulin on clinical outcomes

John B Buse, Melanie J Davies, Brian M Frier, Athena Philis-Tsimikas

24 January 2024

Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records

William Doran, Louis Tunnicliffe, Rutendo Muzambi, Christopher T Rentsch, Krishnan Bhaskaran, Liam Smeeth, Carol Brayne, Dylan M Williams, Nish Chaturvedi, Sophie V Eastwood, Susanna J Dunachie, Rohini Mathur, Charlotte Warren-Gash

25 January 2024

A static glucose-stimulated insulin secretion (sGSIS) assay that is significantly predictive of time to diabetes reversal in the human islet bioassay

Ruth Damaris Molano, Antonello Pileggi, Hubert M Tse, Cherie L Stabler, Christopher A Fraker

14 March 2024

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

Odette S Reifsnider, Anuraag R Kansal, Pranav K Gandhi, Lael Cragin, Sarah B Brand, Egon Pfarr, Kyle Fahrbach, Anastasia Ustyugova

24 January 2024

Should insulin resistance (HOMA-IR), insulin secretion (HOMA-β), and visceral fat area be considered for improving the performance of diabetes risk prediction models

Huan Hu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Tetsuya Mizoue

8 January 2024

Trigger finger is associated with risk of incident cardiovascular disease in individuals with type 2 diabetes: a retrospective cohort study

Yusuke Mineoka, Michiyo Ishii, Yoshitaka Hashimoto, Hiroki Yuge, Machiko Toyoda, Naoto Nakamura, Yasukazu Katsumi, Michiaki Fukui

24 January 2024

Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin

Kristina M Utzschneider, Naji Younes, Neda Rasouli, Joshua I Barzilay, Mary Ann Banerji, Robert M Cohen, Erica V Gonzalez, Faramarz Ismail-Beigi, Kieren J Mather, Philip Raskin, Deborah J Wexler, John M Lachin, Steven E Kahn

24 January 2024

Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review

Julio Rosenstock, Harpreet S Bajaj, Ildiko Lingvay, Simon R Heller

14 May 2024